1. Sheline GE. Pituitarv tumours radiation therapy. In Beardwelt C and Robertson GE.(eds) Clinical Endocrinology. 1. The Pituitary'. pp 106-139 (1981) London. Butterworths.
2. Brada , Rajan B. Traish D et al. The long term efficacy of conservative surgery and radiotherapy in the control of pituitary adenomas . Clinical Endocrinology 38 : 571-578; 1993.
3. Cicarelli EC. Orsello SM Plowman PN et al. Prolonged lowering ofgrowth hormone afier radiotherapy in acromegalic patients followed over 15 vears. Advances in the Biosciences. 260-272 1988.
4. Howlett TA. Plowman PN. Wass JAH et al. Megavoltage pituitary irradiation in the management of Cushing's disease and Nelsons syndrome; long term follow-up. Clin. Endocrinol. 31:309-332 ; 1989.
5. Jenkins PJ, Trainer PJ, Plowman PN, Shand WS. Grossman AB, Wass JAH, Besser GM. The role of prophylactic pituitary radiotherapy in the long-term outcome after adrenalectomy for Cushing's disease. J. Clin. Endocrinol. Metab. 79; 165-171; 1994.
6. Tsagarakis S. Grossman AB. Plowman PN et al. Megavoltage radiotherapy in the management of prolactinomas: long term follow up. Clin. Endocrinol. 31:309-332:1989
7. Harris JR. Levene MB. Visual complications following irradiation for pituitary adenomas and craniopharyngiomas. Radiology 120:167-171; 1976.
8. Aristizabal S, CaIdwell WL, Avila J. The relationship oftime dose fractionation factors to complications in the treatment ofpituitary tumours by irradiation. Int. J. Radiat Oncol. Biol. Phys. 2: 667-673; 1977
9. Atkinson AB. Allen IV. Gordon DS. Progressive visual failure in acromegaly following external pituitary irradiation. Clin. Endocrinol. 10: 469-479:1979.
10. Sheline GE. Role of conventional radiation therapy in the treatment of functional pituitary tumours. In: Linfoot JA (ed): Recent advances in the diagnosis and treament of pituitary tumours. pp 289-313. New York. Raven.
II. Hammer HM. Optic chiasmal radionecrosis. Transactions of the Ophthalmological Society of the UK. 103: 208-211; 1983.
12. MacLeod AF. Clarkes OG. Pambakian H. Treatment of acromegaly by external irradiation. Clin. Endocrinol. 30: 303-314; 1989
13. Jones A. Radiation oncogenesis in relation ot the treatment of pituitary tumours Clinical Endocrinology 35: 379-397: 1991.
14. O' Halleran DJ. Shalet SM. Radiotherapy for pituitary adenomas: an endocrinologist's perspective. Clin. Oncol. 8: 79-84; 1996.
15. Littlev MD, Shalet SM, Beardwell CG. et al. Hypopituitarism following external beam radiotherapy for pituitary' tumours in adults. Quarterly J Med. 70 : 145-160; 1989.
16. Littley MD, Shalet SM, Beardwell CG et al. Radiation induced hypopituitarism is dose dependent. Clin. Endocrinol. 31:363-373; 1989.
17. Shalet SM. Radiation and pituitary dysfunction. New Eng. J. Med. 328: 131-133:1993.
18. Blacklay A. Grossman A. Savage M et al. Cranial irradiation in children with cerebral tumours - evidence for a hypothalamic defect in growth hormone release. J. Endocrinol. 108 : 25-29; 1986
19. Cicarelli E. Corsello SM, Plowman PN. Jones AE. Touzel R, Rees LH. Besser GM. Wass JAil. Long-term effects of radiotherapy for acromegaly on the circulating prolactin. Acta Endocrinol. 121: 827-832; 1989.
20. Rappaport R. Brauner R. Czernichow P et al. Effect of hypothalamic and pitutary, irradiation on pubertal development in children with cranial tumours. J. Clin Endocrinol Metab. 54:1 164-8; 1982.
21. Nicholl RM. Kirk JMW. Grossman AB, Plowman PN. Besser GM. Savage MO. Acceleration of pubertal development following pitutary radiotherapy for Cushing's disease. Clin. Oncol. 5: 393-394; 1993.
22. Wass JAH. Plowman PN, Jones AE, Besser GM. The treatment of acromegaly by external pituitary' irradiation and drugs. In : International Synposium: Challenges in Hypersecretion. Human Growth Hormone. New York: Raven Press. 1985.
23. Feek GCM, MeLelland J, Seth S et al. How effective is external pituitary irradiation for growth hormone secreting pituitary tumours? Clinical Endocrinology. 20: 401-408:1984.
24. Brada M. Ford D. Ashley S et al. Risk of second brain tumour afier conservative surgery, and radiotherapy for pituitary adenoma. Brit. Med. J. 304:1343-1346; 1992.
25. Tsang RW. Laperrier NJ, Simpson w.J. Brierlev J. Panzarella T. Smvth ilS. Glioma arising afler radiation therapy for pituitary adenoma. Cancer 72: 2227-2233:1993.
26. Bliss P, Kerr GR, GregorA. Incidence of second brain tumours after pituitary' irradiation in Edinburgh 1962-1990. Clin. Oncol 6:361-363:1994.
27. Wass JAil, Besser GM, Grossman AB. Plo~~ man PN. Meade TW. Second brain tumour after treatment for pituitary adenoma Brit. Med. J. 305: 253-254:1992.
28. Janoun L. Bloom HJG. Long-term psychological effects in children treated for intracranial tumors. Int. J. Radiat. Oncol. 18: 747-753;1990.
29. Gratton-Smith P]. Morris JG. Shores EA. Batchelor J. Sparks RS Neuropsychological abnormalities in patients with pituitary, tumours. Acta Neurol Scand. 86(6); 626-3 I: 1992
30. Peace KA. Orme SM, Thompson AR. Belchetz PE. Cognitive dysfunction in patients treated for pituitary, tumours J. Clin. Exp. Neuropsychol.19:1-6; 1997.
31. Peace KA, Orme SM, Sebastian JP. Thompson AR. Barnes S. Ellis A. Belchetz PE. The effect oftreatment variables on mood and social adjustment in adult patients with disease. Clin. Endocrinol. 46: 445-450: 1997.
32. Laws ER and Thapar K. Surgical management of pituitary adenomas . In Pituitary' Tumours. Ed J. Fagin. Bailliere's Clinical Endocrinology and metabolism. Bailliere Tindall. London 1995 pp391-406.
33. Comtois R, Beauregard II, Somma M. Serri O. Aris-Jilwan N. Hardy J. The clinical and endocrine outcome to trans-sphenoidal microsurgery of non-functioning pituitary adenomas. Cancer 68: 860-866.1991
34. Lillehei KO, Kirschman DL, Kleinschmidt-Demasters BK, Ridgway EC. Reassessment of the role of radiation therapy in the treatment of endocrine inactive pituitary macroadenomas. Neurosurgery 43: 432-439: 1998.
35. Blevins LS, Chnsty JH, Khajavi M, Tindall GT. Outcomes of therapy for Cushing's disease due to adrenocorticotrophin secreting pituitary, macroadenomas. J. Clin. Endocrinol. Metab 83: 63-67:1998.
36. Fahlbusch R. Honneger J. Buchfelder M. Surgical management of acromegaly. Endocrinol. Metab. North America. 21: 669-692; 1992.
37. Minderman T, Wilson CB. Thyrotrophin producing pituitary adenomas. J. Neurosurg. 64: 402-407:1993.
38. Selman WR. Laws ER, Scheithauer BW, Carpenter Sm. The occurrence of dural invasion in pituitary, adenomas. J. Neurosurg. 64: 402-407.1986.
39. Pegolo G. Buckwalter JG. Weiss MH. Hinton DR. Pituitary adenomas. Correlation of the cytological appearance with biological behaviour. Acta cytol. 39: 8890-892:1995.
40. Landolt AM. Shibata F, Kleihues P. Growth rate of pituitary adenomas. J. Neurosurg 67: 803-806:1987.
41. Shivuva M, Saito F, Miwa Y. Davis RI. Wilson CB. Hoshino T. Histochemical study of pituitary adenomas with Ki-647 and anti-DNA polymerase a monoclonal antibodies. bromodeoxyoridine labelling and nucleolar organiser region counts. ActaNeuropathol. 84: 178-183; 1992.
42. Wilson DW. Hakim F. Biller BMK. Delamonte S, Zeervas NT. Klibanski A. Hadley-Whyte ET. Significance of proliferating cell nuclear antigen index in predicting pituitary, adenoma recurrence. J. Neurosurg. 78: 753-761:1993
43. Gandour-Edwards R, Kapdia SB, Janecka IP. Martinez AJ, Barnes L. Biological markers of invasive pituitary, adenomas involving the cavernous sinus. Modern Pathol. 8:160-164; 1995.
44 Thapar K, Kovacs K, Scheithauer BW, Stefaneanu L, Horvath E, Pernicone PJ, Murray D. Laws ER. Proliferative activity and invasiveness among pituitary, adenomas and carcinomas an analysis using the MIB-1 antibody. Neurosurgery, 38; 99-107; 1996.
45 Knosp E, Kitz K, Pereczkv A. Proliferation activity in pituitarv adenomas : measurement b' monoclonal antibody ki-647. Neurosurg. 25: 927-930:1989.
46. Takino H, Herman V, Weiss M, Melmed S. Purine binding factor (nm-23) gene expression in poituitary' tumours; marker of adenoma invasiveness. J. Clin. Endocrinol. Metab. 80: 1733-1738; 1995.
47. Thapar K. Scheithauer BW. Kovacs K. Pernicone P]. Laws ER. p-53 expression in pituitary adenomas and carcinomas : correlation with invasiveness and tumour growth fractions. Neurosurg 38 : 765-771; 1996.
48. LeRiche VK, Asa SL.. Ezzat S. Epidermal growth factor and its receptor (RGF-R) in human pituitary adenomas : EGFR correlates with tumor aggressiveness. J. Clin. Endocrinol. Metab. 81:656-662; 1996.
49. Alvaro V. Touraine P. Vozari RR. Bai-Grenier F. Birman P, Joubert D. Protein kinase C activity and expression in normal and adenomatous human pituitaries. Int. J. Cancer. 50: 724-730; 1992
50. Dahia PLM, Aguir RCT. Honegger J. Fahlbusch R, Jordan S. Lowe DG. Lu X. Clayton RN. Besser GM, Grossman AB. Mutation and expression analysis of the p27/kip I gene in corticotrophin secreting tumours. Oneogene 16:69-76.1998
SI. Podgorsak EB, Pike GB, Pla M, Oliver A, Souhami L. Radiosurgery, with photon beams : physical aspects and adequacy of linear accelerators. Radiotherapy and Oncology 17:349-358:1990
52. Luxton GB, Petrovitch Z. JozsofG. Nedzi LA, Apuzzo MJL. Stercotactic radiosurgery : a comparison of treatment methods. Neurosurgery, 32:241-259; 1993.
53. Phillips MH, Stelzer, KJ, Griffin TW. Maybcrg MR, Winn HR. Stereotactic radiosurgery': a review and comparison of methods . J. Clin. Oncol.12:1085-1099:1994.
54. Verhey U. Smith V. Serago CF. Comparison of radiosurgery' treament modalities based on physical dose distributions. Int. J. Radiat. Oncol. Biol. Phvs. 40: 497-505; 1998.
55. Plowman PN. Doughty D. Stereotactic Radiosurgery X. Clinical isodosimetry of gamma knife versus X-knife for pituitary and acoustic tumours. Brit J Neurosurg I (MS submitted).
56. Kjellberg RN. Kliman B. Life-time effectiveness ; a system of therapy for pituitary adenomas, emphasising Bragg peak proton hypophysectomy In Recent advances in the diagnosis and treatment of pituitary tumors Ed. Linfoot JA. New York. Raven press. 1979; 269-286.
57. Degerblad M, Rahn T. Bergstrand G Thoren M. Long-term results of stereotactic radiosurgery to the pituitary gland in Cushing's Disease. Acta Endocrinol. 112:310-314: 1986.
58. Thoren M, Rahn T, Guo W. Werner S. Sterotactic radiosurgery, with cobalt-60 gamma unit in the treatment of growth hormone producing pituitary' tumours. Neurosurgery 29: 663-668; 1991.
59. Pollock BE, Kondziolka D. Lunsford LD. Flickinger J. Stereotactic radiosurgery' for pituitary, adenomas : imaging, visual and endocrine results. ActaNeurochir. 62: 33-38 1994(suppl.).
60. Park YG. Chang JW. Kim Ly. Chung SS. Gamma knife in pituitary microadenomas. Yonsei Med Journal 37(3): 165-173:1996.
61. Yoon SC. Sub TS, Jang ilS. Chung SM. Kim YS. Ryu MR. Choi KH. Kim MC. Shion KS. Clinical results of 24 pituitary macroadenomas with linac based stereotactic radiosurgery. Int. J Radiat Oncol Biol Phys. 41: 849-853:1998.
62. Voges J. Storm V Deus U, Traud C, Trcuer. Schlegel W. Winkelmann W. Muller RP. Linac radiosurgery, (LINAC-RS) in pituitary, adenomas preliminary results. Acta Neurochir. 65 :41-43: 1996(suppl).
63. Landolt AM, Hailer D, Lomax N. Scheib S, Schubiger 0. Siegfried J, Wellis G. Stereotactic radiosurgery, for recurrent surgically treated acromegaly : a comparison with fractionated radiotherapy. J. Neurosurgery 88:1002-1008; 1998.
64.Biersmasz NR, Van Dulken H, Roelfsma F. Long term follow-up results of post-operative radiotherapy in 36 patients with acromegaly. J Clin Endocrinol Metab. 85: 2476-2482: 2000.
65. Powell JS. Wardlaw St., Post KD, Freda PU. Outcome of radiotherapy for acromegaly using normalisation of insulin like growth factor I to define cure.Clin Endocrinol Metab 85: 2068-2071: 2000.
66. Orth DN, Liddle GW. Results of treatment in 108 patients with Cushing's syndrome. New Eng J Med. 1971; 285: 243-7.
67. Ross WM. Evered DC, Hunter P. Benaim M. Cook D. Hall R Treatment of Cushing's disease with adrenal blocking drugs and megavoltage radiotherapy to the pituitary. Clinical Radiology 1979:30:149-53.
68. Lamberts SWJ. De Lange SA. Singh R. Fermin H. Klijn JGM. De Jong FH. Birkenhager JC. The treatment of Cushing's disease: a comparison between the results of transsphenoidal operation and those of unilateral adrenalectomy followed by external pituitary, irradiation. Netherlands Journal of Medicine 1980: 23:193-9.